Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/a-1198-4785
Through-the-needle forceps biopsy for pancreatic cystic lesions: multiple meta-analyses but limited prospective data
![](https://www.thieme-connect.de/media/10.1055-s-00025476/202009/lookinside/thumbnails/1930_10-1055-a-1198-4785-1.jpg)
With the mounting quality and utilization of cross-sectional imaging, pancreatic cystic lesions (PCLs) increasingly are being identified, particularly in asymptomatic and elderly patients. However, accurate classification among the various PCLs remains a persistent clinical challenge with the current standard-of-care diagnostic tools, consisting of endoscopic ultrasound (EUS), fine-needle aspiration (FNA), cyst fluid analysis (CEA), and cytology. While the primary challenge is in accurate differentiation of mucinous from non-mucinous PCLs, precise identification of mucinous PCLs with advanced neoplasia (high-grade dysplasia and/or adenocarcinoma) is also difficult. There have thus been several guidelines for management of pancreas cysts, but these still result in modest diagnostic accuracy. In fact, EUS-FNA has a sensitivity of at most 63 % for malignant PCLs with inadequate specimens in up to two-thirds of cases. Given these findings, up to 30 % of PCLs are incorrectly diagnosed as mucinous cysts, resulting in a large number of unnecessary surgical resections with postoperative morbidity approaching 40 % [1]. Improved accuracy in classifying PCLs, therefore, would reduce unwarranted pancreatic surgeries and associated complications, and save costs on unwarranted follow-up. Because of this, enormous effort has been put into development and evaluation of novel diagnostic modalities for PCLs, including cyst fluid molecular analysis, confocal laser endomicroscopy (CLE), and through-the-(EUS) needle microforceps.
Publication History
Article published online:
31 August 2020
© 2020. Owner and Copyright ©
© Georg Thieme Verlag KG
Stuttgart · New York
-
References
- 1 Valsangkar NP, Morales-Oyarvide V, Thayer SP. et al. 851 resected cystic tumors of the pancreas: A 33-year experience at the Massachusetts General Hospital. Surgery 2012; 152: S4-12
- 2 Guzman-Calderon E, Martinez B, Casellas J. Endoscopic ultrasound-guided, through-the-needle forceps biopsy for the diagnosis of pancreatic cystic lesions: a systematic review. Endosc Int Open 2020; 8: E1123-E1133
- 3 Yang D, Trindade AJ, Yachimski P. et al. Histologic analysis of endoscopic ultrasound-guided through the needle microforceps biopsies accurately identifies mucinous pancreas cysts. Clin Gastroenterol Hepatol 2019; 17: 1587-1596
- 4 Tacelli M, Celsa C, Magro B. et al. Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta-analysis. Dig Endosc 2020; DOI: 10.1111/den.13626.
- 5 Facciorusso A, Del Prete V, Antonino M. et al. Diagnostic yield of EUS-guided through-the-needle biopsy in pancreatic cysts: a meta-analysis. Gastrointest Endosc 2020; DOI: 10.1016/j.gie.2020.01.038.
- 6 Durkin C, Krishna SG, Singhi AD. et al. Advanced diagnostics for pancreatic cysts: Confocal endomicroscopy and molecular analysis. World J Gastroenterol 2019; 25: 2734-2742
- 7 Krishna SG, Hart PA, Malli A. et al. Endoscopic ultrasound-guided confocal laser endomicroscopy increases accuracy of differentiation of pancreatic cystic lesions. Clin Gastroenterol Hepatol 2020; 18: 432-440.e436
- 8 Cheesman AR, Zhu H, Liao X. et al. Impact of EUS-guided microforceps biopsy sampling and needle-based confocal laser endomicroscopy on the diagnostic yield and clinical management of pancreatic cystic lesions. Gastrointest Endosc 2020; 91: 1095-1104